China Shineway Pharmaceutical Group Limited Stock
Stocks
2877
KYG2110P1000
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.930 HKD | -0.38% |
|
-4.80% | -7.79% |
| 05-07 | China Shineway Pharmaceutical's Turnover Slides 18% in Q1 | MT |
| 05-07 | China Shineway Pharmaceutical posts Q1 turnover of RMB624 mln | RE |
| Market Cap | 5.16B 5.99B 764M 661M 617M 567M 1.07B 72.62B 1.08B 7.25B 2.84B 36.33B 2.87B 2.81B 120B | P/E 2026 * |
5.42x | P/E 2027 * | 4.83x |
|---|---|---|---|---|---|
| Enterprise Value | 5.16B 5.99B 764M 661M 617M 567M 1.07B 72.62B 1.08B 7.25B 2.84B 36.33B 2.87B 2.81B 120B | EV / Sales 2026 * |
1.7x | EV / Sales 2027 * | 1.58x |
| Free-Float |
33.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.38% | ||
| 1 week | -4.80% | ||
| Current month | -2.82% | ||
| 1 month | +2.85% | ||
| 3 months | -16.44% | ||
| 6 months | -18.58% | ||
| Current year | -7.79% |
| 1 week | 7.9 |  | 8.32 |
| 1 month | 7.46 | | 8.5 |
| Current year | 7.21 | | 10.47 |
| 1 year | 7.21 | | 10.47 |
| 3 years | 6.55 | | 10.76 |
| 5 years | 4.63 | | 10.76 |
| 10 years | 4.6 | | 18.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
King Kuen Hung
IRC | Investor Relations Contact | 60 | - |
Baochang Liu
SAM | Sales & Marketing | 46 | 01/12/2019 |
Bun Ching Lee
AUD | Comptroller/Controller/Auditor | 53 | 01/02/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhen Jiang Li
CHM | Chairman | 70 | 14/08/2002 |
Yun Xia Xin
BRD | Director/Board Member | 62 | 14/08/2002 |
Hui Min Li
BRD | Director/Board Member | 58 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/31/22 A | Other | Director | 280,000 | 0.0339% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.38% | -4.80% | -4.00% | -5.14% | 767M | |
| +0.57% | -2.50% | +22.30% | +68.07% | 48.95B | |
| +3.09% | +7.65% | +60.81% | +132.38% | 39.36B | |
| +1.25% | +0.72% | -0.65% | +20.70% | 12.39B | |
| -1.17% | -0.64% | +18.79% | +69.11% | 11.76B | |
| +1.53% | -0.38% | +30.75% | +134.53% | 9.14B | |
| -0.08% | +3.15% | +18.38% | +33.96% | 7.05B | |
| +1.61% | -4.86% | +36.73% | -14.17% | 6.86B | |
| +0.49% | +3.64% | +12.07% | +178.19% | 6.7B | |
| +0.79% | +3.84% | -29.57% | +15.81% | 5.67B | |
| Average | +0.76% | -0.76% | +16.56% | +63.34% | 14.87B | |
| Weighted average by Cap. | +1.23% | -0.35% | +28.73% | +82.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.03B 3.52B 449M 389M 363M 334M 630M 42.73B 637M 4.26B 1.67B 21.38B 1.69B 1.65B 70.81B | 3.26B 3.79B 483M 419M 390M 359M 678M 45.96B 685M 4.59B 1.8B 22.99B 1.82B 1.78B 76.16B |
| Net income | 956M 1.11B 142M 123M 114M 105M 198M 13.46B 201M 1.34B 527M 6.74B 532M 520M 22.31B | 1.07B 1.25B 159M 138M 128M 118M 223M 15.1B 225M 1.51B 591M 7.55B 596M 583M 25.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | HK$7.930 | -0.38% | 511,000 |
| 05/08/26 | HK$7.960 | 0.00% | 405,525 |
| 04/08/26 | HK$7.960 | -1.30% | 464,000 |
| 03/08/26 | HK$8.065 | -1.16% | 444,391 |
| 31/07/26 | HK$8.160 | -2.04% | 583,099 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2877 Stock
Select your edition
All financial news and data tailored to specific country editions
